SANIFORT PHARMA: what changed
What changed
SANIFORT PHARMA
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Net result for the year
€75,588
2024 · €61,896+€13,692
Equity
-€3.6m
2024 · -€3.7m+€75,588
Cash
€41,325
2024 · €65,950-€24,625
Balance sheet total
€408,425
2024 · €608,182-€199,758
Largest movements
Assets
- Stocks and contracts -€103,451
down €103,451 (-52.8%), from €195,756 to €92,305
- Receivables within one year -€78,851
down €78,851 (-23.4%), from €336,496 to €257,645
of which Trade receivables: -€76,441
- Cash -€24,625
down €24,625 (-37.3%), from €65,950 to €41,325
mainly Trade debts (-€194,013) and Debts after one year (-€87,500)
Equity and liabilities
- Trade debts -€194,013
down €194,013 (-23.7%), from €819,929 to €625,916
- Debts after one year -€87,500
down €87,500 (-3.4%), from €2.6m to €2.5m
- Profit (loss) carried forward +€75,588
up €75,588 (+2.0%), from -€3.8m to -€3.8m
- Tax, wage and social debts +€6,167
up €6,167 (+224%), from €2,747 to €8,914
of which Remuneration and social security: +€5,291
Income statement
- Gross operating margin -€9,156
down €9,156 (-8.1%), from €113,027 to €103,870
- Staff costs -€7,760
down €7,760 (-28.2%), from €27,470 to €19,710
- Financial charges -€1,391
down €1,391 (-22.0%), from €6,319 to €4,928
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€61,896
Gross operating margin
-€9,156
Staff costs
+€7,760
Depreciation
-€701
Other operating charges
-€571
Other operating items
+€14,608
Financial income
+€5
Financial charges
+€1,391
Taxes
+€357
Result 2025
€75,588
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€70,878
Investment
-€8,004
Financing
-€87,500
Cash 2024
€65,950
From operations (derived)
+€70,878
Net result for the year
+€75,588
Depreciation
+€1,858
Stocks and contracts
+€103,451
Receivables within one year
+€78,851
Deferred charges and accrued income
-€1,024
Trade debts
-€194,013
Tax, wage and social debts
+€6,167
Investment (derived)
-€8,004
Investment in fixed assets (net)
-€8,004
Financing
-€87,500
Debts after one year
-€87,500
Cash 2025
€41,325
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €608,182 | €408,425 | -€199,758 | -32.8% |
| Fixed assets | 21/28 | €8,499 | €14,645 | +€6,146 | +72.3% |
| Intangible fixed assets | 21 | - | €4,919 | +€4,919 | |
| Tangible fixed assets | 22/27 | €3,351 | €4,578 | +€1,227 | +36.6% |
| Furniture and vehicles | 24 | €3,351 | €4,578 | +€1,227 | +36.6% |
| Financial fixed assets | 28 | €5,149 | €5,149 | = | 0.0% |
| Current assets | 29/58 | €599,683 | €393,779 | -€205,904 | -34.3% |
| Stocks and contracts in progress | 3 | €195,756 | €92,305 | -€103,451 | -52.8% |
| Stocks | 30/36 | €195,756 | €92,305 | -€103,451 | -52.8% |
| Amounts receivable within one year | 40/41 | €336,496 | €257,645 | -€78,851 | -23.4% |
| Trade receivables | 40 | €324,988 | €248,547 | -€76,441 | -23.5% |
| Other amounts receivable | 41 | €11,508 | €9,098 | -€2,411 | -20.9% |
| Cash at bank and in hand | 54/58 | €65,950 | €41,325 | -€24,625 | -37.3% |
| Deferred charges and accrued income | 490/1 | €1,481 | €2,505 | +€1,024 | +69.1% |
| Total equity and liabilities | 10/49 | €608,182 | €408,425 | -€199,758 | -32.8% |
| Equity | 10/15 | -€3,672,310 | -€3,596,722 | +€75,588 | +2.1% |
| Contributions | 10/11 | €162,500 | €162,500 | = | 0.0% |
| Capital | 10 | €162,500 | €162,500 | = | 0.0% |
| Issued capital | 100 | €162,500 | €162,500 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€3,834,810 | -€3,759,222 | +€75,588 | +2.0% |
| Amounts payable | 17/49 | €4,280,492 | €4,005,147 | -€275,346 | -6.4% |
| Amounts payable after more than one year | 17 | €2,562,092 | €2,474,592 | -€87,500 | -3.4% |
| Financial debts | 170/4 | €2,562,092 | €2,474,592 | -€87,500 | -3.4% |
| Amounts payable within one year | 42/48 | €1,650,176 | €1,462,330 | -€187,846 | -11.4% |
| Current portion of amounts payable after more than one year | 42 | €62,500 | €62,500 | = | 0.0% |
| Trade debts | 44 | €819,929 | €625,916 | -€194,013 | -23.7% |
| Suppliers | 440/4 | €819,929 | €625,916 | -€194,013 | -23.7% |
| Taxes, remuneration and social security | 45 | €2,747 | €8,914 | +€6,167 | +224% |
| Taxes | 450/3 | €477 | €1,353 | +€875 | +183% |
| Remuneration and social security | 454/9 | €2,270 | €7,561 | +€5,291 | +233% |
| Other amounts payable | 47/48 | €765,000 | €765,000 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €68,225 | €68,225 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €27,470 | €19,710 | -€7,760 | -28.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,157 | €1,858 | +€701 | +60.6% |
| Other operating charges | 640/8 | €1,099 | €1,670 | +€571 | +51.9% |
| Non-recurring operating charges | 66A | €14,608 | €0 | -€14,608 | -100% |
| Gross operating margin | 9900 | €113,027 | €103,870 | -€9,156 | -8.1% |
| Operating profit (loss) | 9901 | €68,692 | €80,632 | +€11,940 | +17.4% |
| Financial income | 75/76B | €0 | €5 | +€5 | |
| Recurring financial income | 75 | €0 | €5 | +€5 | |
| Financial charges | 65/66B | €6,319 | €4,928 | -€1,391 | -22.0% |
| Recurring financial charges | 65 | €6,319 | €4,928 | -€1,391 | -22.0% |
| Profit (loss) for the period before taxes | 9903 | €62,373 | €75,709 | +€13,336 | +21.4% |
| Income taxes | 67/77 | €477 | €121 | -€357 | -74.7% |
| Profit (loss) for the period | 9904 | €61,896 | €75,588 | +€13,692 | +22.1% |
| Profit (loss) for the period to be appropriated | 9905 | €61,896 | €75,588 | +€13,692 | +22.1% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.